Compare CORT & MXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | MXL |
|---|---|---|
| Founded | 1998 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 8.5B |
| IPO Year | 2001 | 2009 |
| Metric | CORT | MXL |
|---|---|---|
| Price | $113.79 | $86.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $96.50 | $41.67 |
| AVG Volume (30 Days) | 823.3K | ★ 2.1M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.08 |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $761,407,000.00 | $478,596,000.00 |
| Revenue This Year | $26.08 | $22.10 |
| Revenue Next Year | $26.98 | $10.70 |
| P/E Ratio | $1,224.56 | ★ N/A |
| Revenue Growth | ★ 12.79 | N/A |
| 52 Week Low | $28.66 | $12.77 |
| 52 Week High | $126.38 | $128.30 |
| Indicator | CORT | MXL |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 64.22 |
| Support Level | $108.25 | $79.18 |
| Resistance Level | $124.30 | $89.00 |
| Average True Range (ATR) | 5.29 | 4.59 |
| MACD | -0.76 | 2.60 |
| Stochastic Oscillator | 61.04 | 92.83 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.